Compound ID | 533

Update compound information

MUT37307

Class: Fatty acid synthesis inhibitor (FabI inhibitor)

Spectrum of activity: Gram-positive
Details of activity: Inhibits FabI, which determins the completing of each cycle of elongation in the fatty acid synthesis.
Description: Escaich S, Prouvensier L, Saccomani M, et al. MUT37307 FabI inhibitor: in vitro and in vivo antibacterial activity against Staphylococcal aureus. 48-ICAAC-46-IDSA-2008 2008;278
Institute where first reported: Mutabilis (Fab Pharma., France)
Year first mentioned: 2008
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 251.23
Iso. SMILES: CCC1=CC(=C(C=C1F)OC2=C(N=CC=C2)F)O
InChI Key: BJEMGBNLIALWCL-UHFFFAOYSA-N
Can. SMILES: CCC1=C(C=C(C(=C1)O)OC2=CC=CN=C2F)F
InChI: InChI=1S/C13H11F2NO2/c1-2-8-6-10(17)12(7-9(8)14)18-11-4-3-5-16-13(11)15/h3-7,17H,2H2,1H3
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/25020641
Citations:
  • https://journals.asm.org/doi/10.1128/cmr.00030-10

  • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.